MedTrace Logo

Psychobiological Responses to Choral Singing in Mentally Ill and Healthy Children and Adolescents

NCT04454736 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2022-05-19

No results posted yet for this study

Summary

Interventional, three-armed, open, monocentric, medium-term follow-up, pre-test-post-test design, controlled, parallel group study to investigate the effects of a group singing intervention on neuroendocrine (hair cortisol, salivary cortisol, salivary alpha amylase), immune (salivary immunoglobulin A/s-IgA), and psychological (psychological stress, mood, social contacts, emotional and social competence, self-esteem, and quality of life) responses in mentally ill and healthy children and adolescents (N=135, age range 10 -18).

Additionally, the child and adolescent psychiatry group (age range 13-18) takes part in three hour creative workshops every two weeks.

Conditions

  • Stress

Interventions

BEHAVIORAL

"Amateur" Group Singing

45-minute singing session led by a professional choirmaster without a therapeutic background once a week

BEHAVIORAL

"Professional" Group Singing

120-minute singing session led by a professional choirmaster without a therapeutic background three times a week. Assessments take place twice a week.

Sponsors & Collaborators

  • Universität Mozartuem Salzburg

    collaborator UNKNOWN

  • Salzburger Landeskliniken

    collaborator OTHER

  • Paracelsus Medical University

    collaborator OTHER

  • University of Vienna

    collaborator OTHER

  • University of Salzburg

    lead OTHER

Principal Investigators

  • Katarzyna Grebosz-Haring, Dr. · University Mozarteum Salzburg, University of Salzburg

  • Leonhard Thun-Hohenstein, Prof. Dr. · Salzburger Landeskliniken Betriebsges.m.b.H.

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-12-31
Completion
2023-07-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04454736 on ClinicalTrials.gov